335 related articles for article (PubMed ID: 34138894)
1. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of postoperatif controlling nutritional status (CONUT) score in glioblastoma multiforme.
Yılmaz H; Niğdelioğlu B; Oktay E; Meydan N
J Clin Neurosci; 2021 Apr; 86():260-266. PubMed ID: 33775339
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
[TBL] [Abstract][Full Text] [Related]
8. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.
Bambury RM; Teo MY; Power DG; Yusuf A; Murray S; Battley JE; Drake C; O'Dea P; Bermingham N; Keohane C; Grossman SA; Moylan EJ; O'Reilly S
J Neurooncol; 2013 Aug; 114(1):149-54. PubMed ID: 23780645
[TBL] [Abstract][Full Text] [Related]
9. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin.
Oba T; Maeno K; Ono M; Ito T; Kanai T; Ito KI
Anticancer Res; 2021 Jan; 41(1):445-452. PubMed ID: 33419842
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.
Mirili C; Yılmaz A; Demirkan S; Bilici M; Basol Tekin S
Int J Clin Oncol; 2019 Oct; 24(10):1301-1310. PubMed ID: 31073814
[TBL] [Abstract][Full Text] [Related]
12. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study.
Kim YJ; Oh H; Lee SJ; Kim KM; Kang H; Park CK; Park HP
BMC Cancer; 2021 Aug; 21(1):942. PubMed ID: 34418999
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants.
Alimohammadi E; Bagheri SR; Sadeghsalehi A; Rizevandi P; Rezaie Z; Abdi A
Acta Neurol Belg; 2020 Dec; 120(6):1341-1350. PubMed ID: 31222512
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Indicators of Systemic Inflammatory Response on Survival in Glioblastoma Multiforme.
Mermut O; Inanc B
Turk Neurosurg; 2020; 30(5):658-665. PubMed ID: 32530473
[TBL] [Abstract][Full Text] [Related]
20. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.
McNamara MG; Lwin Z; Jiang H; Templeton AJ; Zadeh G; Bernstein M; Chung C; Millar BA; Laperriere N; Mason WP
J Neurooncol; 2014 Mar; 117(1):147-52. PubMed ID: 24469854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]